Feasibility and safety of a transvenous lead extraction program implementation in South America: Challenges, early outcomes, and global collaboration-A single-center experience
- PMID: 36589010
- PMCID: PMC9795241
- DOI: 10.1016/j.hroo.2022.07.012
Feasibility and safety of a transvenous lead extraction program implementation in South America: Challenges, early outcomes, and global collaboration-A single-center experience
Abstract
Background: Transvenous lead extraction is the standard of care for cardiac implantable electronic device (CIED) malfunction/infection-related removal. However, data on its performance and results in underdeveloped countries are limited.
Objective: The purpose of this study was to report the feasibility and efficacy of a lead extraction program in a tertiary hospital in Chile, South America.
Methods: Patients requiring CIED removal at the Electrophysiology Division of the Hospital las Higuera's were retrospectively analyzed. Outcomes including procedure-related mortality, procedural success and failure, and cardiac and vascular complications were reported.
Results: A total of 15 patients were analyzed (median age 68 [interquartile range 52-75] years; 80% male). Patients with lead extraction difficulty index >10 represented 33% of patients. Infection was the indication for removal in all patients, with pocket infection (80%). Mechanical rotational tools were used in 66% of cases, and a total of 29 leads were removed. Procedural success was accomplished in 93% of cases. There was 1 (7%) intraprocedural complication and no procedure-related mortality.
Conclusions: The development of a lead management program is feasible, safe, and effective in underdeveloped countries.
Keywords: Electrophysiology; Lead complications; Lead extraction; Lead management; South America.
© 2022 Heart Rhythm Society. Published by Elsevier Inc.
Figures
References
-
- Sohail M.R., Henrikson C.A., Braid-Forbes M.J., Forbes K.F., Lerner D.J. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171:1821–1828. - PubMed
-
- Lee J.Z., Majmundar M., Kumar A., et al. Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices. Heart Rhythm. 2022;19:768–775. - PubMed
-
- Kusumoto F.M., Schoenfeld M.H., Wilkoff B.L., et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–e551. - PubMed
-
- Bontempi L., Vassanelli F., Cerini M., et al. Predicting the difficulty of a transvenous lead extraction procedure: validation of the LED index. J Cardiovasc Electrophysiol. 2017;28:811–818. - PubMed
-
- Krainski F., Pretorius V., Birgersdotter-Green U. A practical approach to lead removal: transvenous tools and techniques. Card Electrophysiol Clin. 2018;10:637–650. - PubMed
LinkOut - more resources
Full Text Sources
